User:Hooman Khorasani/sandbox

Hooman Khorasani, M.D.
EducationUCLA
USC Medical School
Medical career
Professiondermatologist
InstitutionsThe Mount Sinai Hospital

Hooman Khorasani, M.D., is the Chief of the Division of Dermatologic and Cosmetic Surgery at Mount Sinai School of Medicine and a double board certified, fellowship-trained skin cancer and cosmetic surgeon. He is a diplomat of the American Board of Dermatology (Procedural Dermatology) and the American Board of Cosmetic Surgery (Dermatologic Cosmetic Surgery).

Biography

edit

Dr. Khorasani graduated summa cum laude from UCLA with a degree in Physiological Sciences and graduated in the top 5% of his medical school with highest distinction from the University of Southern California.

Following medical school, Dr. Khorasani completed his internship in General Surgery at the USC-LA County Hospital, gaining extensive exposure to trauma and reconstructive surgery. He then completed a research fellowship in Plastic Surgery at the University of Southern California School of Medicine where he studied minimal scar wound repair.

Dr. Khorasani served as chief resident and completed his dermatology residency at NYMC Metropolitan Hospital and Montefiore North in New York City. After his residency, Dr. Khorasani completed a fellowship in Procedural Dermatology and Mohs micrographic surgery at The Mount Sinai Medical Center where he had additional training in skin cancer surgery, reconstructive surgery and cosmetic surgery.

Dr. Khorasani has specialized training in advanced skin cancer screening and management (Melanoma, Basal & Squamous Cell Carcinomas). He is an expert in Mohs micrographic surgery and post Mohs reconstructive surgery. As one of the co-founders of the Tisch Cancer Institute’s Melanoma and Skin Cancer Center, Dr. Khorasani is actively involved with clinical trials and the advancement of skin cancer therapy.Dr. Khorasani is also a fellowship-trained cosmetic surgeon who performs cosmetic procedures including liposuction, various laser procedures, scar revisions, blepharoplasty (eye lift), Botox, filler and fat injections. Dr.Khorsani's is intensely interested in minimal scar wound repair, and he has done extensive research in this area. In particular, he has focused on the molecular agents involved in fetal scarless wound healing including TGF family of molecules and Fibromodulin. Dr. Khorasani has presented his work at multiple national meetings.

Khorasani's research also includes scar analysis of post Mohs micrographic surgery wounds treated with ablative CO2 resurfacing using fractal analysis and lacunarity to objectively analyze wounds treated with ablative fractional CO2 laser post surgery.

Awards and honors

edit
  • 2011 Teacher of the Year
  • Mount Sinai School of Medicine Dep. of Dermatology For Excellence in Resident and Fellow Teaching
  • Member of the Alpha Omega Alpha Honor Medical Society, American Society of Dermatologic Surgery, American Academy of Dermatology and American College of Mohs Micrographic Surgery and Cutaneous Oncology

Publications

edit
  • Khorasani H, Zheng Z, Nguyen C, Zara J, Zhang X, Wang J, Ting K, Soo C. A quantitative approach to scar analysis. The American journal of pathology 2011 Feb; 178(2).
  • Zheng Z, Nguyen C, Zhang X, Khorasani H, Wang JZ, Zara JN, Chu F, Yin W, Pang S, Le A, Ting K, Soo C. Delayed wound closure in fibromodulin-deficient mice is associated with increased TGF-β3 signaling. The Journal of investigative dermatology 2011 Mar; 131(3).
  • Chotiner JK, Khorasani H, Nairn AC, O'Dell TJ, Watson JB. Adenylyl cyclase-dependent form of chemical long-term potentiation triggers translational regulation at the elongation step. Neuroscience 2003; 116(3).
  • Watson JB, Khorasani H, Persson A, Huang KP, Huang FL, O'Dell TJ. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II. Journal of neuroscience research 2002 Nov; 70(3).

References

edit
edit